Pancreatic Cancer Research

ResearcherUniversity of PisaActive in the last 2 years

Barbara Włodarczyk

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0742-2305; OpenAlex author ID A5033049658. Sources: OpenAlex.

Their work

Papers
11
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: 2 papers · 2025: 2 papers

Papers 11

  1. Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer. Co-author DOI 10.1016/j.semcancer.2024.12.005↗
  2. Pancreatic Cancer Detection in Intraductal Papillary Mucinous Neoplasm (IPMN)-New Insights. Co-author DOI 10.3390/cancers17203341↗
  3. Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk. Co-author DOI 10.1186/s40246-024-00576-x↗
  4. Select Endocrine Disorders and Exosomes in Early PDAC Diagnosis. Co-author DOI 10.3390/ijms252212159↗
  5. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2023.104020↗
  6. CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation. Co-author DOI 10.3390/jcm12124050↗
  7. Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk. Co-author DOI 10.3389/fgene.2021.693933↗
  8. Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pa… Co-author DOI 10.5114/pg.2020.95091↗
  9. Serum Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor-binding Protein 2 as a Novel Biomarker in the Detection of Pancreatic Adenocarcinom… Co-author DOI 10.1097/mcg.0000000000001297↗
  10. The Role of Insulin-like Growth Factor (IGF) Axis in Early Diagnosis of Pancreatic Adenocarcinoma (PDAC). Co-author DOI 10.1097/mcg.0000000000001073↗
  11. Evaluation of insulin-like growth factor (IGF-1) and retinol binding protein (RBP-4) levels in patients with newly diagnosed pancreatic adenocarcinoma (PDAC). Co-author DOI 10.1016/j.pan.2017.04.001↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ewa I. Malecka-Panas · 6 shared papers, 2017–2024 · strength 1.07
  2. Łukasz Durko · 3 shared papers, 2023–2025 · strength 0.85
  3. Anita Gąsiorowska · 4 shared papers, 2017–2021 · strength 0.55
  4. Renata Talar‐Wojnarowska · 2 shared papers, 2023–2024 · strength 0.52
  5. Wojciech Pawłowski · 1 shared paper, 2025 · strength 0.33
  6. Ewa Małecka-Wojciesko · 1 shared paper, 2025 · strength 0.33
  7. Paolo Riccardo Camisa · 1 shared paper, 2025 · strength 0.25
  8. Chiara Corradi · 1 shared paper, 2025 · strength 0.25
  9. Volkan N. Adsay · 1 shared paper, 2025 · strength 0.25
  10. Gabriele Capurso · 1 shared paper, 2025 · strength 0.25
  11. Daniele Campa · 1 shared paper, 2025 · strength 0.25
  12. Francesca Tavano · 1 shared paper, 2025 · strength 0.25
  13. Manuel Gentiluomo · 1 shared paper, 2025 · strength 0.25
  14. Stefano Crippa · 1 shared paper, 2025 · strength 0.25
  15. Juan Sáinz · 1 shared paper, 2025 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.